September 19, 2014
The Japan Pharmaceutical Manufacturers Association (JPMA) has slapped Takeda Pharmaceutical Chairman Yasuchika Hasegawa with another six-month suspension on his vice president duties at the JPMA after a third party probe confirmed the company’s improper organizational involvement in the CASE-J study...read more